Medicure Inc. reported unaudited consolidated earnings results for the second quarter and six months ended November 30, 2011. For the quarter, total net revenue increased to CAD 2.2 million from CAD 0.8 million for the same quarter last year. The increase in revenue for the second quarter of fiscal 2012 is largely attributable to a one-time sale to Iroko Cardio LLC, of which all conditions of the sale were met during the second quarter. Net income was CAD 1.1 million or CAD 0.01 per basic and diluted share, compared to CAD 0.7 million or CAD 0.01 per basic and diluted share in the second quarter a year ago. For the six months ended November 30, 2011, net income was CAD 24.6 million or CAD 0.15 per basic and diluted share, compared to a loss of CAD 0.9 million or CAD 0.01 per basic and diluted share for the same period a year ago, primarily due to a CAD 23.9 million non cash gain relating to the settlement of the companies long-term debt in the first quarter as well as the one-time sale. Cash flows from operating activities were CAD 1,829,361, compared to cash flows used in operating activities of CAD 29,878 for the six months ended November 30, 2010. Acquisition of property and equipment was CAD 1,488 as compared to CAD 1,787 for the same period prior year. Acquisition of intangible assets amounted to CAD 15,487 as compared to CAD 29,973 for the same period prior year.